MedPath

Comparative study of bupivacaine and levobupivacaine with adjuvant buprenorphine in brachial plexus block in upper limb surgeries

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/02/063071
Lead Sponsor
JSS Academy of Higher Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age between 18 years-60 years

- ASA-PS I and II

- Posted for upper limb surgeries

Exclusion Criteria

-Patient not giving consent

-Coagulopathy

-Neuropathy

-Pregnancy

-Hemodynamic instability

-Allergic history to local anesthetic

-Local infection, open wound , distorted anatomy in the affected side of neck and supraclavicular area due to hematoma, swelling

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the effect of block and duration of analgesia by adding adjuvant buprenorphine to bupivacaine and levobupivacaineTimepoint: From giving supraclavicular brachial plexus block to 24 hours postoperative period
Secondary Outcome Measures
NameTimeMethod
To determine onset and duration of sensory block using Holmen scale, to determine onset and duration of motor block using modified bromage scale, to determine total duration of postoperative analgesia using VAS score, any side effects like nausea, vomiting, pruritis, respiratory depressionTimepoint: From giving supraclavicular brachial plexus block to 24 hours postoperative period
© Copyright 2025. All Rights Reserved by MedPath